Jane Street’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-42,378
| Closed | -$113K | – | 6754 |
|
|
2024
Q1 | $113K | Sell |
42,378
-34,887
| -45% | -$92.8K | ﹤0.01% | 5231 |
|
|
2023
Q4 | $183K | Buy |
77,265
+52,750
| +215% | +$125K | ﹤0.01% | 5060 |
|
|
2023
Q3 | $34.3K | Sell |
24,515
-106,978
| -81% | -$150K | ﹤0.01% | 4824 |
|
|
2023
Q2 | $398K | Buy |
131,493
+115,082
| +701% | +$349K | ﹤0.01% | 3969 |
|
|
2023
Q1 | $103K | Buy |
16,411
+3,842
| +31% | +$24K | ﹤0.01% | 4938 |
|
|
2022
Q4 | $76.7K | Buy |
+12,569
| New | +$76.7K | ﹤0.01% | 4779 |
|
|
2022
Q3 | – | Sell |
-11,636
| Closed | -$147K | – | 6522 |
|
|
2022
Q2 | $147K | Buy |
+11,636
| New | +$147K | ﹤0.01% | 4602 |
|
|
2021
Q1 | – | Sell |
-6,049
| Closed | -$241K | – | 5498 |
|
|
2020
Q4 | $241K | Buy |
+6,049
| New | +$241K | ﹤0.01% | 3342 |
|